Cargando…

Enhanced Prefrontal Regional Homogeneity and Its Correlations With Cognitive Dysfunction/Psychopathology in Patients With First-Diagnosed and Drug-Naive Schizophrenia

Background: Schizophrenia, regarded as a neurodevelopmental disorder, is characterized by positive symptoms, negative symptoms, and cognitive dysfunction. Investigating the spontaneous brain activity in patients with schizophrenia can help us understand the underlying pathophysiologic mechanism of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Shuzhan, Ming, Yidan, Wang, Jiayin, Gu, Yuan, Ni, Sulin, Lu, Shuiping, Zhang, Rongrong, Sun, Jing, Zhang, Ning, Xu, Xijia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649771/
https://www.ncbi.nlm.nih.gov/pubmed/33192722
http://dx.doi.org/10.3389/fpsyt.2020.580570
_version_ 1783607388800024576
author Gao, Shuzhan
Ming, Yidan
Wang, Jiayin
Gu, Yuan
Ni, Sulin
Lu, Shuiping
Zhang, Rongrong
Sun, Jing
Zhang, Ning
Xu, Xijia
author_facet Gao, Shuzhan
Ming, Yidan
Wang, Jiayin
Gu, Yuan
Ni, Sulin
Lu, Shuiping
Zhang, Rongrong
Sun, Jing
Zhang, Ning
Xu, Xijia
author_sort Gao, Shuzhan
collection PubMed
description Background: Schizophrenia, regarded as a neurodevelopmental disorder, is characterized by positive symptoms, negative symptoms, and cognitive dysfunction. Investigating the spontaneous brain activity in patients with schizophrenia can help us understand the underlying pathophysiologic mechanism of schizophrenia. However, results concerning abnormal neural activities and their correlations with cognitive dysfunction/psychopathology of patients with schizophrenia were inconsistent. Methods: We recruited 57 first-diagnosed and drug-naive patients with schizophrenia and 50 matched healthy controls underwent magnetic resonance imaging. The Positive and Negative Syndrome Scale (PANSS) and the MATRICS Consensus Cognitive Battery were used to assess the psychopathology/cognitive dysfunction. Regional homogeneity (ReHo) was used to explore neural activities. Correlation analyses were calculated between abnormal ReHo values and PANSS scores/standardized cognitive scores. Lastly, support vector machine analyses were conducted to evaluate the accuracy of abnormal ReHo values in distinguishing patients with schizophrenia from healthy controls. Results: Patients with schizophrenia showed cognitive dysfunction, and increased ReHo values in the right gyrus rectus, right inferior frontal gyrus/insula and left inferior frontal gyrus/insula compared with those of healthy controls. The ReHo values in the right inferior frontal gyrus/insula were positively correlated with negative symptom scores and negatively correlated with Hopkins verbal learning test-revised/verbal learning. Our results showed that the combination of increased ReHo values in the left inferior frontal gyrus/insula and right gyrus rectus had 78.5% (84/107) accuracy, 85.96% (49/57) sensitivity, and 70.00% specificity, which were higher than other combinations. Conclusions: Hyperactivities were primarily located in the prefrontal regions, and increased ReHo values in the right inferior frontal gyrus/insula might reflect the severity of negative symptoms and verbal learning abilities. The combined increases of ReHo values in these regions might be an underlying biomarker in differentiating patients with schizophrenia from healthy controls.
format Online
Article
Text
id pubmed-7649771
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76497712020-11-13 Enhanced Prefrontal Regional Homogeneity and Its Correlations With Cognitive Dysfunction/Psychopathology in Patients With First-Diagnosed and Drug-Naive Schizophrenia Gao, Shuzhan Ming, Yidan Wang, Jiayin Gu, Yuan Ni, Sulin Lu, Shuiping Zhang, Rongrong Sun, Jing Zhang, Ning Xu, Xijia Front Psychiatry Psychiatry Background: Schizophrenia, regarded as a neurodevelopmental disorder, is characterized by positive symptoms, negative symptoms, and cognitive dysfunction. Investigating the spontaneous brain activity in patients with schizophrenia can help us understand the underlying pathophysiologic mechanism of schizophrenia. However, results concerning abnormal neural activities and their correlations with cognitive dysfunction/psychopathology of patients with schizophrenia were inconsistent. Methods: We recruited 57 first-diagnosed and drug-naive patients with schizophrenia and 50 matched healthy controls underwent magnetic resonance imaging. The Positive and Negative Syndrome Scale (PANSS) and the MATRICS Consensus Cognitive Battery were used to assess the psychopathology/cognitive dysfunction. Regional homogeneity (ReHo) was used to explore neural activities. Correlation analyses were calculated between abnormal ReHo values and PANSS scores/standardized cognitive scores. Lastly, support vector machine analyses were conducted to evaluate the accuracy of abnormal ReHo values in distinguishing patients with schizophrenia from healthy controls. Results: Patients with schizophrenia showed cognitive dysfunction, and increased ReHo values in the right gyrus rectus, right inferior frontal gyrus/insula and left inferior frontal gyrus/insula compared with those of healthy controls. The ReHo values in the right inferior frontal gyrus/insula were positively correlated with negative symptom scores and negatively correlated with Hopkins verbal learning test-revised/verbal learning. Our results showed that the combination of increased ReHo values in the left inferior frontal gyrus/insula and right gyrus rectus had 78.5% (84/107) accuracy, 85.96% (49/57) sensitivity, and 70.00% specificity, which were higher than other combinations. Conclusions: Hyperactivities were primarily located in the prefrontal regions, and increased ReHo values in the right inferior frontal gyrus/insula might reflect the severity of negative symptoms and verbal learning abilities. The combined increases of ReHo values in these regions might be an underlying biomarker in differentiating patients with schizophrenia from healthy controls. Frontiers Media S.A. 2020-10-23 /pmc/articles/PMC7649771/ /pubmed/33192722 http://dx.doi.org/10.3389/fpsyt.2020.580570 Text en Copyright © 2020 Gao, Ming, Wang, Gu, Ni, Lu, Zhang, Sun, Zhang and Xu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Gao, Shuzhan
Ming, Yidan
Wang, Jiayin
Gu, Yuan
Ni, Sulin
Lu, Shuiping
Zhang, Rongrong
Sun, Jing
Zhang, Ning
Xu, Xijia
Enhanced Prefrontal Regional Homogeneity and Its Correlations With Cognitive Dysfunction/Psychopathology in Patients With First-Diagnosed and Drug-Naive Schizophrenia
title Enhanced Prefrontal Regional Homogeneity and Its Correlations With Cognitive Dysfunction/Psychopathology in Patients With First-Diagnosed and Drug-Naive Schizophrenia
title_full Enhanced Prefrontal Regional Homogeneity and Its Correlations With Cognitive Dysfunction/Psychopathology in Patients With First-Diagnosed and Drug-Naive Schizophrenia
title_fullStr Enhanced Prefrontal Regional Homogeneity and Its Correlations With Cognitive Dysfunction/Psychopathology in Patients With First-Diagnosed and Drug-Naive Schizophrenia
title_full_unstemmed Enhanced Prefrontal Regional Homogeneity and Its Correlations With Cognitive Dysfunction/Psychopathology in Patients With First-Diagnosed and Drug-Naive Schizophrenia
title_short Enhanced Prefrontal Regional Homogeneity and Its Correlations With Cognitive Dysfunction/Psychopathology in Patients With First-Diagnosed and Drug-Naive Schizophrenia
title_sort enhanced prefrontal regional homogeneity and its correlations with cognitive dysfunction/psychopathology in patients with first-diagnosed and drug-naive schizophrenia
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649771/
https://www.ncbi.nlm.nih.gov/pubmed/33192722
http://dx.doi.org/10.3389/fpsyt.2020.580570
work_keys_str_mv AT gaoshuzhan enhancedprefrontalregionalhomogeneityanditscorrelationswithcognitivedysfunctionpsychopathologyinpatientswithfirstdiagnosedanddrugnaiveschizophrenia
AT mingyidan enhancedprefrontalregionalhomogeneityanditscorrelationswithcognitivedysfunctionpsychopathologyinpatientswithfirstdiagnosedanddrugnaiveschizophrenia
AT wangjiayin enhancedprefrontalregionalhomogeneityanditscorrelationswithcognitivedysfunctionpsychopathologyinpatientswithfirstdiagnosedanddrugnaiveschizophrenia
AT guyuan enhancedprefrontalregionalhomogeneityanditscorrelationswithcognitivedysfunctionpsychopathologyinpatientswithfirstdiagnosedanddrugnaiveschizophrenia
AT nisulin enhancedprefrontalregionalhomogeneityanditscorrelationswithcognitivedysfunctionpsychopathologyinpatientswithfirstdiagnosedanddrugnaiveschizophrenia
AT lushuiping enhancedprefrontalregionalhomogeneityanditscorrelationswithcognitivedysfunctionpsychopathologyinpatientswithfirstdiagnosedanddrugnaiveschizophrenia
AT zhangrongrong enhancedprefrontalregionalhomogeneityanditscorrelationswithcognitivedysfunctionpsychopathologyinpatientswithfirstdiagnosedanddrugnaiveschizophrenia
AT sunjing enhancedprefrontalregionalhomogeneityanditscorrelationswithcognitivedysfunctionpsychopathologyinpatientswithfirstdiagnosedanddrugnaiveschizophrenia
AT zhangning enhancedprefrontalregionalhomogeneityanditscorrelationswithcognitivedysfunctionpsychopathologyinpatientswithfirstdiagnosedanddrugnaiveschizophrenia
AT xuxijia enhancedprefrontalregionalhomogeneityanditscorrelationswithcognitivedysfunctionpsychopathologyinpatientswithfirstdiagnosedanddrugnaiveschizophrenia